CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-04 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-04 | Chen Shu-Chih Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-05-04 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-03-02 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,873,100 | 1,873,100 | ||
| 2023-03-02 | Guse Kyle CFO, Gen Counsel and Secretary | Grant or award · Stock Option (right to buy) | +557,900 | 557,900 | ||
| 2022-05-13 | Chen Shu-Chih Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-05-13 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-05-13 | Remmel H. Lawrence Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-05-13 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +50,000 | 500,000 | ||
| 2022-05-13 | WEAVER GREGORY L Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-02-24 | Guse Kyle CFO, Gen Counsel and Secretary | Grant or award · Stock Option (right to buy) | +746,667 | 746,667 | ||
| 2022-02-24 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,900,000 | 1,900,000 | ||
| 2021-07-02 | WEAVER GREGORY L Director | Option exercise | +4,581 | $5.64 | $26K | 4,581 |
| 2021-07-02 | WEAVER GREGORY L Director | Option exercise | +45,000 | $2.38 | $107K | 49,581 |
| 2021-07-02 | WEAVER GREGORY L Director | Option exercise | +45,000 | $2.52 | $113K | 94,581 |
| 2021-07-02 | WEAVER GREGORY L Director | Option exercise | +70,000 | $1.70 | $119K | 164,581 |
| 2021-07-02 | WEAVER GREGORY L Director | Shares withheld for taxes | −57,084 | $6.40 | $365K | 107,497 |
| 2021-07-02 | WEAVER GREGORY L Director | Sale | −107,497 | $5.58 | $600K | 0 |
| 2021-07-02 | WEAVER GREGORY L Director | Option exercise · Stock Option (right to buy) | −4,581 | 0 | ||
| 2021-07-02 | WEAVER GREGORY L Director | Option exercise · Stock Option (right to buy) | −45,000 | 0 |
Page 3 of 9 · 168 trades